• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sionna Therapeutics, Inc. - Common Stock (NQ:SION)

4.500 -46.540 (-91.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 38,644,425
Open 4.850
Bid (Size) 4.400 (100)
Ask (Size) 4.420 (100)
Prev. Close 51.04
Today's Range 4.010 - 5.000
52wk Range 4.010 - 54.97
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Sionna Halts SION-719 After Phase 2a Miss, Eyes SION-451 Combination Path ↗
Today 0:03 EDT
Sionna Therapeutics (NASDAQ:SION) said its PreciSION CF Phase 2a proof-of-concept study of SION-719 added to Trikafta did not meet its key activity endpoint, prompting the company to discontinue... 
Via MarketBeat
News headline image
Sionna Therapeutics Reports Topline Data from Two Development Programs in Cystic Fibrosis and Provides Corporate Update
August 10, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire

Performance

YTD
-88.5%
-88.5%
1 Month
-89.8%
-89.8%
3 Month
-90.2%
-90.2%
6 Month
-87.8%
-87.8%
1 Year
-77.5%
-77.5%

More News

Read More
News headline image
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire? ↗
August 07, 2026
Via The Motley Fool
News headline image
Sionna Therapeutics Reports Second Quarter 2026 Financial Results
August 06, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
May 27, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference
May 13, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics Reports First Quarter 2026 Financial Results
May 12, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Insider Sells $2.5 Million in Stock Amid 215% Surge, but Here's What Investors Should Watch ↗
April 27, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Sionna Therapeutics Completes Enrollment in PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, Added to Standard of Care in Participants with Cystic Fibrosis
April 27, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics to Participate in the Raymond James 2026 Biotech Innovation Symposium
April 07, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Chief Legal Officer Cashed Out Her Shares. Her Options Are Another Story ↗
March 30, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ENAVATE's Zenas Bio Pharma add Is a Footnote — The Obexelimab Pipeline Is What to Watch ↗
March 21, 2026
Via The Motley Fool
News headline image
Sionna Stock Is Up 144% This Past Year. Is the Biotech a Buy as One Fund Makes a $7 Million Bet? ↗
March 18, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares ↗
March 15, 2026
Via The Motley Fool
News headline image
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
March 02, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit 2026
February 04, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares ↗
January 12, 2026
Via The Motley Fool
Topics Initial Public Offering Regulatory Compliance
News headline image
Sionna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
A Sionna Therapeutics (SION) Insider Sold 33,000 Shares for $1.5 Million ↗
January 03, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Sionna Therapeutics to Participate in Upcoming December Investor Conferences
November 24, 2025
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics Reports Third Quarter 2025 Financial Results
November 05, 2025
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
Sionna Therapeutics to Participate in Upcoming November Investor Conferences
November 04, 2025
From Sionna Therapeutics, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
October 28, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
October 27, 2025
Via Benzinga

Frequently Asked Questions

Is Sionna Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sionna Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sionna Therapeutics, Inc. - Common Stock trade on?
Sionna Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sionna Therapeutics, Inc. - Common Stock?
The ticker symbol for Sionna Therapeutics, Inc. - Common Stock is SION on the Nasdaq Stock Market
What is the current price of Sionna Therapeutics, Inc. - Common Stock?
The current price of Sionna Therapeutics, Inc. - Common Stock is 4.500
When was Sionna Therapeutics, Inc. - Common Stock last traded?
The last trade of Sionna Therapeutics, Inc. - Common Stock was at 08/10/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap